The MACD remains negative, but is rising... suggesting a possible near-term correction. Of companies with a negative, but rising MACD, Chemed is ranked 35.
|Up Estimate Revision
During the past month, the consensus earnings estimate for the current year and next year have increased by a combined 0.80%. Among companies that have had their estimates raised within the past month, Chemed is ranked 173.
Within the past 90 days Chemed has provided guidance above the consensus estimates. Statistics show companies that provide positive guidance outperform the market in the short-term.
Chemed has a low Put/Call ratio of 0.30 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Chemed is ranked 877.
|Up EPS Surprise
Chemed beat the consensus earnings estimate when it last reported quarterly earnings.
The StockSelector Value for Chemed is $327.70. The StockSelector Value assumes the market consistently prices a stock around a given PE ratio and, therefore, multiplies the average PE (using forward earnings estimates) over the past three years by future earnings estimates. Among companies with a StockSelector Value above the current stock price, Chemed is ranked 1552.
|10 Day Gain
Chemed rank is 3146
Chemed has a high Put/Call ratio of 0.45 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Chemed is ranked 2188.
|90 Day Loss
Chemed rank is 2403